COMPANIES COVERED
NovartisDownload FREE Report Sample
Download Free sampleAcromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.
Acromegaly Market contains market size and forecasts of Acromegaly in Global, including the following market information:
Global Acromegaly Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Acromegaly market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Somatostatin Analogues Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Acromegaly include Novartis, Aegis Therapeutics, Chiasma, Crinetics Pharmaceuticals, Daewoong Pharmaceutical, Peptron, Silence Therapeutics, Strongbridge Biopharma and Amryt Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acromegaly companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acromegaly Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Acromegaly Market Segment Percentages, by Type, 2021 (%)
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Global Acromegaly Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Acromegaly Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Acromegaly Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Acromegaly Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acromegaly revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Acromegaly revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Foresee Pharmaceuticals
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy